Impact of Obstructive Sleep Apnea in Patients with Acute Heart Failure: A Nationwide Cohort Study

Impact of Obstructive Sleep Apnea in Patients with Acute Heart Failure: A Nationwide Cohort Study

Background/Objectives: Heart failure presents a significant public health challenge, affecting millions in the US, with projections of increasing prevalence and economic burdens. Obstructive sleep apnea (OSA) is highly prevalent among HF patients. This study analyzes the impact of OSA on the outcome...

Full description

Saved in:

Bibliographic Details
Main Authors:	Abdulmajeed Alharbi, Nahush Bansal, Anas Alsughayer, Momin Shah, Waleed Alruwaili, Mohammed Mhanna, Halah Alfatlawi, Eun Seo Kwak, Ayman Salih, Mohanad Qwaider, Ragheb Assaly
Format:	Article
Language:	English
Published:	MDPI AG 2024-11-01
Series:	Hearts
Subjects:	heart failure obstructive sleep apnea heart failure with reduced ejection fraction heart failure with preserved ejection fraction OSA
Online Access:	https://www.mdpi.com/2673-3846/5/4/40
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Improved cardiac and venous pressures during hospital stay in patients with acute heart failure: an echocardiography and biomarkers study
by: Eiichi Akiyama, et al.
Published: (2020-06-01)

IL‐6 and hsCRP predict cardiovascular mortality in patients with heart failure with preserved ejection fraction
by: Martin Berger, et al.
Published: (2024-12-01)

Characteristics, Predictors, and Clinical Outcomes in Heart Failure With Reduced Ejection Fraction According to a 1‐Year Left Ventricular Ejection Fraction Following Sacubitril/Valsartan Treatment
by: Chan Soon Park, et al.
Published: (2024-11-01)

Characteristics, outcomes and the necessity of continued guideline-directed medical therapy in patients with heart failure with improved ejection fraction
by: Qin-Fen Chen, et al.
Published: (2025-12-01)

Circulating Cell-Free Nuclear DNA Predicted an Improvement of Systolic Left Ventricular Function in Individuals with Chronic Heart Failure with Reduced Ejection Fraction
by: Tetiana Berezina, et al.
Published: (2024-10-01)

Elevating Expectations: Vericiguat in Heart Failure with Reduced Ejection Fraction
by: Pushpraj Patel, et al.
Published: (2024-12-01)

Transthyretin cardiac amyloid: Broad heart failure phenotypic spectrum and implications for diagnosis
by: Mileydis Alonso, et al.
Published: (2024-12-01)

Economic impact of heart failure with preserved ejection fraction: insights from the ALDO‐DHF trial
by: Djawid Hashemi, et al.
Published: (2020-06-01)

Editorial: Cardiac reverse remodeling after novel heart failure therapies—volume II
by: Christian Basile, et al.
Published: (2025-01-01)

Prognostic Value of Epicardial Adipose Tissue in Heart Failure With Mid‐Range and Preserved Ejection Fraction: A Multicenter Study
by: Wenxian Wang, et al.
Published: (2024-12-01)

Rehospitalization burden and morbidity risk in patients with heart failure with mid‐range ejection fraction
by: Enrique Santas, et al.
Published: (2020-06-01)

Clinical study on the treatment of chronic heart failure with a novel D‐shant atrium shunt device
by: Xiaoke Shang, et al.
Published: (2022-06-01)

Chronic obstructive pulmonary disease and heart failure in real life: the tip of the iceberg in the sea of comorbidities. A prospective observational study
by: Ombretta Para, et al.
Published: (2025-02-01)

Clinical characteristics and outcomes in Asian patients with heart failure with mildly reduced ejection fraction
by: Julian Cheong Kiat Tay, et al.
Published: (2024-07-01)

Heart failure with mildly reduced ejection fraction: retrospective study of ejection fraction trajectory risk
by: Robert J.H. Miller, et al.
Published: (2022-06-01)

Clinical phenotypes of heart failure patients with supranormal ejection fraction
by: Liyan Huang, et al.
Published: (2024-12-01)

Electrocardiography-based artificial intelligence predicts the upcoming future of heart failure with mildly reduced ejection fraction
by: Dae-Young Kim, et al.
Published: (2025-02-01)

Predictors and Long‐Term Clinical Impact of Heart Failure With Improved Ejection Fraction After Acute Myocardial Infarction
by: Kyung An Kim, et al.
Published: (2024-08-01)

Cigarette Smoking, Smoking Cessation, and Heart Failure Subtypes: Insights From the Jackson Heart Study
by: Daisuke Kamimura, et al.
Published: (2024-12-01)

Prevalence and independent predictors of Iron deficiency in Yemeni patients with congestive heart failure: a retrospective cross-sectional study
by: Mohammed Abdullah, et al.
Published: (2024-11-01)

Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial
by: Rolf Wachter, et al.
Published: (2020-06-01)

Clinical characteristics and frailty status in heart failure with preserved vs. reduced ejection fraction
by: Tomoyuki Hamada, et al.
Published: (2022-06-01)

First report of the clinical characteristics and outcomes of cardiac amyloidosis in Saudi Arabia
by: Omar Ahmad, et al.
Published: (2024-12-01)

Sodium‐glucose cotransporter‐2 inhibitors in heart failure: an updated meta‐analysis
by: Yang Cao, et al.
Published: (2022-06-01)

J-shaped association between serum glucose potassium ratio and prognosis in heart failure with preserved ejection fraction with stronger predictive value in non-diabetic patients
by: Liang Shan, et al.
Published: (2024-12-01)

Serum creatinine to cystatin C ratio in relation to heart failure with preserved ejection fraction
by: Ruting Wang, et al.
Published: (2024-12-01)

Efficacy of vericiguat in patients with chronic heart failure and reduced ejection fraction: a prospective observational study
by: Yinge Zhan, et al.
Published: (2025-02-01)

Epidemiological Profile and Correlates for Left Ventricular Diastolic Dysfunction among Patients Attending a Tertiary Health Facility in India
by: Bijay P. Yadav, et al.
Published: (2024-11-01)

CLINICAL FEATURES OF HEART FAILURE WITH LOW EJECTION FRACTION COMBINED WITH ANEMIA
by: Konstantin Viktorovich Protasov, et al.
Published: (2023-09-01)

Performance of the novel ANTWERP score in predicting heart function improvement after atrial fibrillation ablation in Asian patients with heart failure
by: Lo‐Chieh Ling, et al.
Published: (2024-12-01)

Rates and predictors of cardiovascular and non‐cardiovascular outcomes in heart failure with preserved ejection fraction
by: Angiza Shahim, et al.
Published: (2024-12-01)

Cardiac manifestation of phenylketonuria in adulthood
by: Péter Homródi, et al.
Published: (2024-12-01)

Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fraction
by: Anouk Achten, et al.
Published: (2025-04-01)

Características clínicas y tratamiento farmacológico de los pacientes con insuficiencia cardíaca en una cohorte de atención primaria
by: Maria Giner-Sorian, et al.
Published: (2025-07-01)

Long‐Term Risk of Cardiovascular Death in Patients With Mildly Reduced Ejection Fraction After Acute Myocardial Infarction: A Multicenter, Prospective Registry Study
by: Hwajung Kim, et al.
Published: (2024-09-01)

Clinical profile of an unselected population with heart failure treated with vericiguat in real life: differences with the VICTORIA trial
by: Alberto Esteban-Fernández, et al.
Published: (2025-01-01)

Advanced heart failure: guideline‐directed medical therapy, diuretics, inotropes, and palliative care
by: Daniela Tomasoni, et al.
Published: (2022-06-01)

Efficacy of angiotensin receptor neprilysin inhibitor for maintenance hemodialysis patients with different types of left ventricular ejection fraction heart failure
by: Jin-cong Li, et al.
Published: (2024-12-01)

Changes in left ventricular systolic function in patients with chronic heart failure with preserved ejection fraction and cardiorenal anemic syndrome
by: Vasylenko V.A.
Published: (2015-09-01)

Challenges in the diagnosis of heart failure with preserved ejection fraction in individuals with obesity
by: Bas M. van Dalen, et al.
Published: (2025-02-01)